Table 5: Comparison of Studies of Lifestyle Intervention vs Pharmacological Agents

Study

Intervention

N

Duration (yrs.)

Risk Reduction (%)

Follow up time (yrs.)

Follow up risk reduction (%)

CVD events/Total mortality reduction (%)

Lifestyle Intervention studies

Da Qing [8,9]

 

Diet

Exercise

Diet and Exercise Control

130

141

126

133

6

31

46

42

20

43

2/4

DPS Finland [10,20]

 

Diet and Physical Activity

Control

265

 

257

3.2

58

7

43

4/43

DPP US [11]

Diet and Physical activity

Metformin

Placebo

1079

 

1073

1082

2.8

58

 

31

10

34

No Data

Pharmacological Intervention studies

DPP US [11]

Metformin

1073

2.8

31

10

18

No Data

TRIPOD [23]

Troglitazone

236

2.5

55

 

 

 

STOP-NIDDM [17,18]

Acarbose

1368

3.2

36

NA

NA

49

DREAM [14]

Rosiglitazone

5269

3.0

60

NA

NA

No Data

XENDOS [24]

Orlistat

3305

4.0

37

NA

NA

No Data